Deep ulcers are associated with increased C-reactive protein in active ulcerative colitis

被引:7
|
作者
Riviere, P. [1 ,2 ]
Le Chevillier, A. [1 ]
Rullier, A. [3 ]
Marty, M. [4 ]
Schurr, E. [2 ]
Lapuyade, B. [5 ]
Celerier, B. [6 ]
Fernandez, B. [6 ]
Bessissow, T. [7 ]
Treton, X. [8 ]
Uzzan, M. [9 ]
Poullenot, F. [1 ]
Berger, A. [1 ]
Zerbib, F. [1 ]
Laharie, D. [1 ]
机构
[1] Univ Bordeaux, Hop Haut Leveque, CHU Bordeaux, Ctr Med Chirurg Magellan,INSERM,CIC 1401,Gastroe, F-33000 Bordeaux, France
[2] McGill Univ Hlth Ctr, Program Infect Dis & Immun Global Hlth, Res Inst, Montreal, PQ, Canada
[3] Univ Bordeaux, Hop Pellegrin, CHU Bordeaux, Pathol Dept, F-33000 Bordeaux, France
[4] Univ Bordeaux, Hop Haut Leveque, Pathol Dept, CHU Bordeaux, F-33000 Bordeaux, France
[5] Univ Bordeaux, Hop Haut Leveque, Ctr Med Chirurg Magellan, CHU Bordeaux,Radiol Dept, F-33000 Bordeaux, France
[6] Univ Bordeaux, Hop Haut Leveque, Ctr Med Chirurg Magellan, CHU Bordeaux,Abdominal Surg Dept, F-33000 Bordeaux, France
[7] McGill Univ, Hlth Ctr, Div Gastroenterol & Hepatol, Montreal, PQ, Canada
[8] Paris IBD Ctr, Grp Hosp Pr Ambroise Pare Hartmann, 25-27 Blvd Victor Hugo, F-92200 Neuilly Sur Seine, France
[9] Paris Est Creteil Univ UPEC, Henri Mondor Hosp, Assistance Publ Hop Paris AP HP, Fed Hosp-Univ True Innovat Therapy immUne disordE, F-94010 Creteil, France
关键词
Ulcerative colitis; Acute severe ulcerative colitis; Severe endoscopic lesions; Deep ulcers; UCEIS; C-reactive protein; Albumin; Endoscopy; PREDICTIVE FACTORS; INFLIXIMAB; CYCLOSPORINE;
D O I
10.1016/j.dld.2023.05.004
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Increased C-reactive protein (CRP) is used to diagnose and predict response to treatment in acute severe ulcerative colitis (UC). Aims: To investigate the connection between CRP elevation and deep ulcers in UC. Methods: Patients with active UC were enrolled in a multicenter prospective cohort and a retrospective cohort of consecutive patients undergoing colectomy from 2012 to 2019. Results: Forty-one (9 (22%) with deep ulcers) patients were included in the prospective cohort: 4/5 (80%) patients with CRP > 100 mg/L, 2/10 (20%) patients with CRP between 30 and 100 mg/L and 3/26 (12%) patients with CRP < 30 mg/L had deep ulcers (p = 0.006). In the retrospective cohort [46 patients (31 (67%) with deep ulcers)], 14/14 (100%) patients with CRP > 100 mg/L, 11/17 (65%) patients with CRP between 30 and 100 mg/l and 6/15 (40%) patients with CRP < 30 mg/L had deep ulcers (p = 0.001). Positive predictive value of CRP > 100 mg/l for presence of deep ulcers was 80% and 100% in both cohorts, respectively. Conclusions: CRP elevation is a robust surrogate marker for presence of deep ulcers in UC. Elevated CRP or presence of deep ulcers could influence the choice of medical therapy in acute severe UC. (c) 2023 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:1194 / 1200
页数:7
相关论文
共 50 条
  • [21] MARKERS OF SYSTEMIC INFLAMMATION IN MODERATE-SEVERE ULCERATIVE COLITIS: WHAT LEVEL OF C-REACTIVE PROTEIN CONSTITUTES ACUTE SEVERE ULCERATIVE COLITIS?
    Croft, Anthony
    Lord, Anton
    Radford-Smith, Graham L.
    GASTROENTEROLOGY, 2018, 154 (06) : S598 - S598
  • [22] Markers of Systemic Inflammation in Acute Attacks of Ulcerative Colitis: What Level of C-reactive Protein Constitutes Severe Colitis?
    Croft, Anthony
    Lord, Anton
    Radford-Smith, Graham
    JOURNAL OF CROHNS & COLITIS, 2022, 16 (07): : 1089 - 1096
  • [23] Cervicalgia with Increased C-reactive Protein Levels
    Bender, B.
    Widmann, G.
    Riechelmann, H.
    Schmutzhard, J.
    RADIOLOGE, 2014, 54 (03): : 262 - 264
  • [24] Increased C-Reactive Protein in Healthy Controls
    McGill, Mitchell R.
    Gronowski, Ann M.
    CLINICAL CHEMISTRY, 2018, 64 (01) : 242 - 243
  • [25] The association of endoscopic and histologic endpoints with faecal calprotectin and C-reactive protein in patients with moderately to severely active ulcerative colitis treated with mirikizumab
    Panaccione, R.
    Sapin, C.
    Chan-Diehl, F. W.
    Moses, R. E.
    Siegmund, B.
    Walsh, A.
    Kobayashi, T.
    Parambir, D. S.
    Travis, S.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : I167 - I168
  • [26] The Effect of Mirikizumab on Fecal Calprotectin and C-Reactive Protein in Phase 3 Studies of Patients With Moderately-to-Severely Active Ulcerative Colitis
    Siegmund, Britta
    Sands, Bruce E.
    Samaan, Karen
    Li, Xingyuan
    Morris, Nathan
    Gibble, Theresa Hunter
    Redondo, Isabel
    Lissoos, Trevor
    D'Haens, Geert
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S543 - S544
  • [27] Significance of C-Reactive Protein and Lysozyme in Crohn's Disease and Ulcerative Colitis Treated with Infliximab and Adalimumab
    Ionescu, Andra Consuela
    Gaman, Laura
    Vasilescu, Alina
    Atanasiu, Valeriu
    Stoian, Irina
    Ionescu, Lucian
    Diculescu, Mircea
    NEUROGASTRO 2017 - MEETING OF THE ROMANIAN SOCIETY OF NEUROGASTROENTEROLOGY WITH ROME IV REGIONAL CENTRAL EAST EUROPEAN MEETING, 2017, : 185 - 189
  • [28] C-reactive protein/albumin ratio: a novel biomarker for monitoring of the disease activity in Ulcerative Colitis patients
    Tomasic, V.
    Biscanin, A.
    Cacic, P.
    Palac, L.
    Dorosulic, Z.
    Kralj, D.
    Babic, F.
    Ogresta, D.
    Hrabar, D.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : I330 - I332
  • [29] Outcomes of human albumin solution infusion in acute severe ulcerative colitis: C-reactive protein response
    Gilhotra, R. A.
    White, L. S.
    Lord, A.
    Howlett, M.
    Radford-Smith, G.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 : 93 - 94
  • [30] CLINICAL AND LABORATORY INDICATORS OF EXTENT OF ULCERATIVE-COLITIS - SERUM C-REACTIVE PROTEIN HELPS THE MOST
    PRANTERA, C
    DAVOLI, M
    LORENZETTI, R
    PALLONE, F
    MARCHEGGIANO, A
    IANNONI, C
    MARIOTTI, S
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 1988, 10 (01) : 41 - 45